Castle Biosciences, Inc. (CSTL) Ownership

$29.36

north_east
$0.75 (2.62%)
Day's range
$27.81
Day's range
$30.46

Castle Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 2.92 M $77.85 M   -6.38% 10.49%
VANGUARD GROUP INC 02/11/2025 1.83 M $48.84 M   4.79% 6.58%
WASATCH ADVISORS LP 02/13/2025 1.80 M $47.87 M   -1.64% 6.45%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 1.44 M $38.26 M   -6.69% 5.16%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 999,466 $26.64 M   15.57% 3.59%
UBS GROUP AG 02/14/2025 812,600 $21.66 M   1,401.09% 2.92%
PORTOLAN CAPITAL MANAGEMENT, LLC 02/13/2025 776,579 $20.70 M   -38.15% 2.79%
BELLEVUE GROUP AG 02/14/2025 745,982 $19.88 M   -40.89% 2.68%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 722,120 $19.24 M   100.00% 2.59%
STATE STREET CORP 02/14/2025 710,212 $18.93 M   4.44% 2.55%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 685,000 $18.26 M   39.92% 2.46%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 628,196 $16.75 M   0.56% 2.26%
MILLENNIUM MANAGEMENT LLC 02/14/2025 548,809 $14.63 M   290.51% 1.97%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 547,104 $14.58 M   9.60% 1.97%
PALISADE CAPITAL MANAGEMENT, LP 02/14/2025 503,442 $13.42 M   0.22% 1.81%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 465,526 $12.41 M   -14.20% 1.67%
GOLDMAN SACHS GROUP INC 02/11/2025 432,750 $11.53 M   78.23% 1.55%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 408,650 $10.89 M   1.85% 1.47%
KORNITZER CAPITAL MANAGEMENT INC /KS 01/31/2025 383,974 $10.23 M   -5.71% 1.38%
ALLIANZ ASSET MANAGEMENT GMBH 02/03/2025 322,374 $8.59 M   356.92% 1.16%
AMERIPRISE FINANCIAL INC 02/14/2025 316,036 $8.42 M   -9.50% 1.14%
PARKMAN HEALTHCARE PARTNERS LLC 02/14/2025 304,629 $8.12 M   2.89% 1.09%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 258,866 $6.90 M   -5.79% 0.93%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/14/2025 252,917 $6.74 M   -61.81% 0.91%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 249,128 $6.64 M   100.00% 0.89%
NEXT CENTURY GROWTH INVESTORS LLC 02/13/2025 235,214 $6.27 M   0.48% 0.84%
INTRINSIC EDGE CAPITAL MANAGEMENT LLC 02/14/2025 232,711 $6.20 M   9.40% 0.84%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 217,544 $5.80 M   276.08% 0.78%
CAPTRUST FINANCIAL ADVISORS 02/14/2025 215,322 $5.74 M   2,567.52% 0.77%
TREXQUANT INVESTMENT LP 02/12/2025 203,571 $5.43 M   27.53% 0.73%
SILVERCREST ASSET MANAGEMENT GROUP LLC 02/14/2025 199,950 $5.33 M   -0.98% 0.72%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 189,101 $5.04 M   2.81% 0.68%
ADVISORS CAPITAL MANAGEMENT, LLC 02/13/2025 178,935 $4.77 M   6.56% 0.64%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 177,537 $4.73 M   -6.84% 0.64%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 168,713 $4.50 M   1.97% 0.61%
SHELTON CAPITAL MANAGEMENT 02/13/2025 164,008 $4.37 M   0.00% 0.59%
ALGERT GLOBAL LLC 02/14/2025 149,491 $3.98 M   11.29% 0.54%
HARBOR CAPITAL ADVISORS, INC. 01/10/2025 118,500 $3.16 M   -23.01% 0.43%
GRANAHAN INVESTMENT MANAGEMENT, LLC 02/14/2025 110,824 $2.95 M   -73.94% 0.40%
JPMORGAN CHASE & CO 02/12/2025 107,936 $2.88 M   55.51% 0.39%
D. E. SHAW & CO., INC. 02/14/2025 90,563 $2.41 M   100.00% 0.33%
BANK OF NEW YORK MELLON CORP 02/04/2025 84,459 $2.25 M   10.29% 0.30%
BIRCHVIEW CAPITAL, LP 02/14/2025 78,000 $2.08 M   34.48% 0.28%
FRANKLIN RESOURCES INC 02/12/2025 73,637 $1.96 M   6.13% 0.26%
HUSSMAN STRATEGIC ADVISORS, INC. 02/03/2025 73,500 $1.96 M   100.00% 0.26%
ENVESTNET ASSET MANAGEMENT INC 02/13/2025 73,344 $1.95 M   8.84% 0.26%
GSA CAPITAL PARTNERS LLP 02/07/2025 70,801 $1.89 M   36.61% 0.25%
TUDOR INVESTMENT CORP ET AL 02/14/2025 70,076 $1.87 M   41.60% 0.25%
AMERICAN CENTURY COMPANIES INC 02/11/2025 69,175 $1.84 M   28.14% 0.25%
ORION PORTFOLIO SOLUTIONS, LLC 02/12/2025 68,316 $1.82 M   -5.65% 0.25%

Castle Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 243 institutional investors and hedge funds held shares of Castle Biosciences, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 2.92 M

VANGUARD GROUP INC: 1.83 M

WASATCH ADVISORS LP: 1.8 M

PRINCIPAL FINANCIAL GROUP INC: 1.44 M

DIMENSIONAL FUND ADVISORS LP: 999,466

UBS Group AG: 812,600

94.82% of Castle Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 30.31 M shares in the last 24 months. This purchase volume represents approximately $889.92 M in transactions.